Arcadia Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Arcadia Biosciences

11/08/2022 22:49

* Arcadia Biosciences Inc  RKDA.OQ  reported a quarterly
adjusted
loss of 20 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 30 cents per share.
    * Revenue rose 174.6% to $3.86 million from a year ago;
analysts
expected $2.29 million. 
    * Arcadia Biosciences Inc's reported EPS for the quarter was
a
loss of 17 cents​.
    * The mean earnings estimate of analysts had risen by
about 9.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Arcadia Biosciences Inc shares had fallen by 8.0% this
quarter and lost 11.5% so far this year.
    * The company reported a quarterly loss of $3.78 million.
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $3.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 09:49 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.30          -0.20          Beat
 Mar. 31 2022      -0.34          -0.20          Beat
 Dec. 31 2021      -0.30          -0.28          Beat
 Sep. 30 2021      -0.29          -0.10          Beat